Home › Interdigitating Dendritic Cell Sarcoma
Interdigitating Dendritic Cell Sarcoma clinical trials recruiting in the U.S.
7 studies for Interdigitating Dendritic Cell Sarcoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
RecruitingPhase 1
1 Day – 21 Years · All sexes · Updated Aug 26, 2026 · NCT05857969This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT07121946SynKIR-310 for Relapsed/Refractory B-NHL
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT06544265Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT06846463A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT06736613Q702 for the Treatment of Patients With Hematologic Malignancies
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT06712810Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Recruiting
Ages 18 and older · All sexes · Updated Oct 9, 2025 · NCT05940272From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.